CrowdOptic
- Industry
- Software, Medical Technology, Computer Hardware
- Founded Year
- 2010
- Headquarters
- 400 Treat Avenue, Suite E, San Francisco, CA 94110, United States
- Employee Count
- 17
Key People
-
Jon Fisher - CEO
Email: fisherjonb@crowdoptic.com
Assessment
- Team
-
Aspect: First-time 10+ yrs
Summary: The leadership team, led by CEO Jon Fisher, has over a decade of experience in technology and entrepreneurship.
Jon Fisher, as CEO, brings significant experience in technology and entrepreneurship, which is crucial for navigating the competitive MedTech landscape.
- Clinical Need
-
Aspect: Good
Summary: CrowdOptic's technology addresses a notable need in medical training and remote collaboration.
The company's focus on enhancing medical training through augmented reality meets a clear need, though the market size is moderate compared to other segments.
- Competition
-
Aspect: Somewhat crowded
Summary: The market has several players offering similar augmented reality solutions in healthcare.
While CrowdOptic has unique patents, the augmented reality space in healthcare is competitive, requiring strategic differentiation.
- Technical Challenge
-
Aspect: Moderate
Summary: Developing and integrating augmented reality solutions in medical settings presents moderate technical challenges.
Implementing augmented reality in healthcare involves integrating with existing systems and ensuring reliability, which are moderate challenges.
- Patent
-
Aspect: Very Strong
Summary: CrowdOptic holds multiple patents, including U.S. Patent No. 9,264,474, strengthening its intellectual property position.
Holding key patents in augmented reality technology enhances CrowdOptic's market position and protects against competitors.
- Financing
-
Aspect: Medium
Summary: The company has raised $17.2 million in funding, indicating moderate financial backing.
The current funding supports operations, but scaling may require further investment.
- Regulatory
-
Aspect: 510k/PMA
Summary: CrowdOptic's products likely require FDA 510(k) clearance or PMA, depending on their classification.
Medical devices must comply with FDA regulations, which can delay time-to-market and increase costs.
Opportunity Rollup
- Odds of Success
- 3.25
- Peak Market Share
- 4.65
- Segment CAGR
- 10.7%
- Market Segment
- Medical Augmented Reality
- Market Sub Segment
- Surgical Training and Remote Collaboration
Year Post Launch | Market Penetration (%) |
---|---|
1 | 0.23 |
2 | 0.70 |
3 | 1.63 |
4 | 3.26 |
5 | 4.65 |
Key Takeaway
CrowdOptic's strong patent portfolio and experienced leadership position it well in the growing medical augmented reality market, though challenges in competition and financing remain.